fully human mAbs targeting cytokines (Humabs BioMed)

N/A

Report date: 2025/03/20 20:00:06

Base Information

Drug Namefully human mAbs targeting cytokines (Humabs BioMed)
Drug Alias NameN/A
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Monoclonal antibody human
Mechanisms of ActionCytokine receptors modulators
TargetsCytokine receptors
Therapy Area/IndicationsN/A
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySwitzerland
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesHumabs Biomed Sa
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesHumabs Biomed Sa
Active IndicationsN/A
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A